Medical "New Infrastructure" In Post Epidemic Era: The "War Epidemic" Sample Of Mindray Medical

The outbreak of new crown pneumonia in 2020 makes China's public health system face an unprecedented test. This is a public health emergency with the fastest transmission speed, the widest range of infection and the most difficult prevention and control since the founding of new China. It also sets an extraordinary keynote for the "new infrastructure" of China's future public health system.

At the beginning of the year, Wuhan, which was in the center of the epidemic situation, all the shelter hospitals and non infectious disease hospitals established in a short period of time in huoshenshan and leishenshan hospitals and the temporary transformation of non infectious disease hospitals all tested the ability of all parties involved.

With the gradual disappearance of the haze of the epidemic, the clinical trials of the new crown vaccine have been gradually completed, and the construction of the health system and public health in the post epidemic era has come to a new crossroads. After the resumption of work and production and sporadic outbreaks, the epidemic control and patient treatment ability faced by large and medium-sized cities have become the focus of public opinion and a new round of test.

From the central government to the local governments, the national development and Reform Commission and the health commission successively issued the "public health prevention and treatment capacity building plan", "the notice on improving the infection prevention and control work in fever clinics and medical institutions", and Shanghai issued "several opinions on improving the major epidemic prevention and control system and mechanism, and improving the public health emergency management system" and other documents ”Construction planning and equipment configuration have a clearer direction.

From the delivery of medical devices and equipment in the epidemic situation, to the continuous coordination of the global supply chain to ensure timely response to sudden manufacturing demand, and to the "revitalization" of the medical system, Mindray medical, as the leader of domestic devices, has participated in every link of this year's "war epidemic".

"As a key medical equipment supplier, Mindray not only played its due role in the epidemic, but also played a beautiful battle. This is mainly because behind the front line of fighting against new crown pneumonia, enterprises in the whole upstream and downstream industrial chain of China's medical device related supporting are working together. " Li Xiting, chairman of Mindray Medical Co., Ltd., said that the so-called "new infrastructure" is a large strategic reserve. "We need to prepare for a rainy day, do a good job in the new reconstruction and expansion of hospitals, so as to deal with public health emergencies more calmly. The new infrastructure will also bring great opportunities to our practitioners. The short board of China's medical industry has been exposed in the epidemic situation, which must be strengthened. "

Public health examination

In addition to challenging the infection prevention and control system of disease control, fever clinics and medical institutions, medical consumables and equipment manufacturers also ushered in a supply war. Masks, protective clothing, ventilators and kits were in urgent need during the epidemic.

Under the high pressure of the epidemic situation, a large number of excellent national medical enterprises have emerged in our country, fighting day and night in the front line of fighting the epidemic at home and abroad. Many enterprises have quickly responded to the overseas epidemic prevention demand and quickly supported the overseas anti epidemic with ventilator, CT, monitor, protective materials and other products. As a leading supplier of medical devices in China, Mindray has always been at the forefront of fighting the epidemic at home and abroad. In the first half of this year, Mindray medical delivered more than 3000 key medical equipment to Huoshen mountain and Leishen mountain in Wuhan, donated 33 million yuan of medical equipment to designated medical institutions in Hubei Province, and delivered nearly 400000 medical equipment globally.

At the 14th National Conference on critical care medicine of the Chinese Medical Association, Guan Xiangdong, the First Affiliated Hospital of Sun Yat sen University, said, "the most familiar brand name we heard in the epidemic situation is Mindray, and the monitors and ventilators are the most handy and favorite among nurses and medical students."

"Many friends know that Mindray is through the ventilator in this year's epidemic. Mindy just did what we could to make the best of what we were good at and played the role of a screw Li Xiting said that these medical devices, which play a key role at the critical moment, were not refined in a day. "Behind them are the support of the entire Chinese medical device industry chain, including R & D, manufacturing, supply chain, market, user service and other links. After nearly 30 years of global market tempering, Mindray is just used in this sudden epidemic. The ability to respond quickly and call for action not only reflects the achievements made in the construction of China's medical and health system in the past 30 years, but also reflects the great progress in the transformation of the achievements of basic science and applied science

Kang Yan, vice chairman of the critical care medicine branch of the Chinese Medical Association and director of the Department of critical care medicine of West China Hospital of Sichuan University, said that in the post epidemic era, the construction of ICU should consider "spatial variability and equipment accessibility", so as to ensure good response to public health emergencies and natural disasters, and realize the "combination of peacetime and wartime".

Li Xiting introduced that in China, Mindray has provided more than 70% of the medical equipment and equipment from the critical ward equipment and inspection equipment of huoshenshan and leishenshan hospitals to Tongji and Xiehe hospitals in Wuhan, Xiaotangshan Hospital and Ditan hospital in Beijing. The manufacturing center in the rear area returned to work from the second day of the new year. The group's efforts were made to improve production capacity and continuously coordinate the global supply chain to ensure timely response to sudden manufacturing demands.

In March this year, the domestic epidemic eased and the overseas epidemic broke out intensively. Mindray received the demand for anti epidemic equipment from more than 100 countries. In Europe, the worst affected country, Italy urgently purchased nearly 10000 monitors and ventilators. After winning the bid, Mindray completed the delivery of the first batch of more than 5000 sets of equipment and hospital installation in 15 days.

Policy guidance

As the first major economy to recover from the impact of the epidemic and restore normal production and living order, China has entered a new medical infrastructure stage in the post epidemic era, such as strengthening the construction of intensive care units, infectious disease hospitals, fever clinics, etc.

According to McKinsey's recent report health first: prescription for prosperity, initial estimates indicate that the epidemic and its subsequent effects may lead to a 3% - 8% decline in global GDP in 2020.

As the world begins to restructure its public health system and rebuild its economy, we have a unique opportunity to rethink health: health is not only a cost to manage, but also an investment direction.

In the next 20 years, through the promotion of existing interventions, the global disease burden is expected to be reduced by about 40%, the disease burden in China can be reduced by about 35%, and more than 70% of the benefits can be obtained through various preventive measures. To seize the opportunity of healthy growth, we need to shift the focus to prevention both inside and outside the health care system. This is not easy and requires all stakeholders to work together to achieve the following four prerequisites: making health a social and economic priority; putting health on everyone's agenda; transforming the health care system; and increasing innovation in areas such as treatment.

Health improvement is expected to increase global GDP by $12 trillion, or 8%, in 2040, equivalent to an annual growth rate of 0.4%; in the same period, China's GDP is expected to rise by 1.8 trillion US dollars, or 5.6%, equivalent to an overall increase of 20% in the baseline GDP growth from 2020 to 2040.

Under the impact of the epidemic, the whole society has realized the importance and urgency of a more sound public health system.

After the national development and Reform Commission issued the "public health prevention and treatment capacity building program" and the National Health Commission issued the "notice on improving the prevention and control of infection in fever clinics and medical institutions", all localities have a clearer direction for the construction planning and equipment configuration. According to the statistics of the Ministry of finance, in the first half of 2020, about 3.5 trillion yuan of local government bonds were issued, including 2.4 trillion yuan of special bonds. In addition, the state also issued 1 trillion yuan of special anti epidemic bonds to support local governments to invest in infrastructure including new medical infrastructure.

At the same time, the epidemic also exposed the weak links of infectious disease hospitals. From the perspective of hospital construction, the situation that infected patients can not be admitted to conventional hospitals reflects the objective problems of infectious disease prevention and control infrastructure, such as space, air conditioning, personnel movement line, sewage and other conditions do not match, so it is difficult to treat patients and control infection.

On February 8, 2020, the National Health Commission and the Ministry of housing and urban rural development issued the guidelines for the design of emergency treatment facilities for new type of coronavirus pneumonia (Trial), which guides the reconstruction, expansion and new construction projects of medical institutions or temporary buildings for centralized treatment of patients with new coronavirus pneumonia from the aspects of site selection, architectural design, water supply and drainage, heating and ventilation.

Sun Wenwen, senior engineer of Zhongyuan International Medical Architecture Design and Research Institute, believes that "the design of infectious disease hospitals in China was relatively weak in the early stage. After all, there were only 167 infectious disease specialized hospitals among more than 30000 hospitals in China. Therefore, after this battle, the construction of specialized infectious disease hospitals and the upgrading and transformation of infectious disease departments of general hospitals will be further accelerated, and a number of hospitals in the form of "peacetime and wartime" may emerge. This is not only related to how the construction technology can empower the peacetime and wartime hospitals, but also to establish a preventive public health and epidemic prevention system from the perspective of long-term investment. "

Supplement the short board

From the perspective of policy, the State supports the construction of public health system in the post epidemic era. Under the policy support, many enterprises have made more exploration and attempt for the medical "new infrastructure".

The essence of new infrastructure is the infrastructure construction of information digitization. From the point of view of this anti epidemic, it has become a deep reform that must be carried out in the medical industry to improve the efficiency of resource allocation of the medical system through the new generation of information technology. For example, in the field of remote diagnosis and treatment, 5g network supports high reliability and low delay transmission of massive data, which breaks through the limitation of space, making it possible for doctors to share resources, which greatly improves the efficiency of diagnosis and treatment, and reduces the risk of doctors' exposure to infection.

For example, "ruizhilian" solution provided by Mindray connects all bedside devices, realizes cross department / Cross Hospital linkage, ensures doctors to view patient data anytime and anywhere, and constructs panorama from Internet of things layer, bedside monitoring and display layer, remote data display layer to clinical data output layer.

In the stage of paying attention to the construction of medical system, the innovation and reform of pharmaceutical industry will also accelerate, and the independent innovation ability of enterprises is more important. The government has also been calling on us to make up for the shortcomings of China's high-end medical equipment, speed up the key core technology research, break through the bottleneck of technical equipment, and realize the independent control of high-end medical equipment.

Li Xiting pointed out that at present, China's medical manufacturing industry is faced with a weak industrial base, which is large but not strong.

From the industry point of view, at present, the domestic parts manufacturing enterprises are still not enough investment and enthusiasm in various aspects, so they have little output and have not mastered the key technologies. "The industrial chain is still very weak, and various disciplines and technologies in key fields are not so proficient. For example, a piece of ordinary steel plate is required for mechanical processing and equipment, but the board is not smooth, and various parts are fixed on it. Every place is a little bit worse, and in the end, it is much worse, resulting in a lot of difference in the overall equipment. If we compete with products made in developed countries, we can't compete. "

First of all, it is very important to improve the industrial chain structure. Medical devices can not be completed by the efforts of one enterprise. "Take Mindray as an example, we need to quickly start more than 800 upstream suppliers to resume work and production, so as to ensure the demand for emergency equipment for first-line rescue patients." Li Xiting proposed to promote the upstream and downstream cooperation of the industrial chain through policies at the national level, improve the ability to resist risks, and enhance the enthusiasm of parts enterprises to put into production through multiple channels. On the other hand, in the process of internationalization, it is also necessary to diversify the layout and constantly improve the ability of global supply chain to replace and restructure.

Second, "only great markets can produce big companies." Li called on medical experts in domestic medical institutions to give more opportunities to domestic equipment. To create a good competitive environment can give domestic equipment more opportunities to use. "Domestic medical device enterprises should combine with hospital clinic in R & D and innovation. Some of the products that come out of the enterprise laboratory are likely to be out of touch with the actual use of the hospital, which will make medical staff have no sense of trust in domestic products. "

In the field of domestic medical devices, the industry is relatively scattered, the strength of enterprises is relatively weak, the overall R & D investment is insufficient, and the price war is prevalent. There are more than 18000 medical device enterprises in China, and more than 90% of them are under 20 million yuan. China also needs aircraft carrier level enterprises with independent R & D capabilities.

Li Xiting believes that "if we want to seize the opportunity and open up the situation at the turning point of this era, we need each of us to do a good part of what we are good at and improve the whole industrial chain, so as to hold the Chinese market as soon as possible.".

?